Involving patients more meaningfully in the industry's activities means getting more serious about their emotional wellbeing.
Julian Upton
Advertisement
Julian Upton is the European Editor of Pharmaceutical Executive and Editor of Pharm Exec Global Digest. He can be reached at jupton@advanstar.com.
Articles by Julian Upton
BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
Q&A explores the evolution of the patient-centric supply chain and how it's poised to impact the clinical trials landscape.
Advertisement
Latest Updated Articles
The Emergence of the Patient-Centric Supply ChainPublished: October 1st 2017 | Updated:
BMS and Biomarker Research: An Interview with Saurabh SahaPublished: May 1st 2018 | Updated:
- Engaging with Emotions: Patients as Partners
Published: February 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
3
Overcoming Recruitment and Retention Barriers in Alzheimer’s and Dementia Studies
4
AI Everywhere: Architecting the Future of Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
